Showing results (3331-3340 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|September 7, 2019
Pediatric NUT Carcinoma Is a Rare and Challenging Tumor: Single Center Experience of Five ChildrenMaya Prasad, Akshay Baheti, Mukta Ramadwar, et al.
The Oncologist|September 7, 2019
The Oncology Data Network (ODN): A Collaborative European Data-Sharing Platform to Inform Cancer CareDavid Kerr, Dirk Arnold, Jean-Yves Blay, et al.
The Oncologist|August 18, 2019
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE TrialDavid R Spigel, Dianna L Shipley, David M Waterhouse, et al.
The Oncologist|August 27, 2020
Cladribine with Granulocyte Colony-Stimulating Factor, Cytarabine, and Aclarubicin Regimen in Refractory/Relapsed Acute Myeloid Leukemia: A Phase II Multicenter StudyHua Wang, Liang Wang, Chun Li, et al.
The Oncologist|April 13, 2011
Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institutionHonghai Dai, Zhouguang Hui, Wei Ji, et al.
The Oncologist|March 12, 2011
A preclinical and clinical study of lithium in low-grade neuroendocrine tumorsSam J Lubner, Muthusamy Kunnimalaiyaan, Kyle D Holen, et al.
The Oncologist|March 24, 2011
18F-FDG PET/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site: a literature reviewAnne Kirstine Hundahl Moller, Annika Loft, Anne Kiil Berthelsen, et al.
The Oncologist|April 1, 2011
Predictive value of in vitro mutation data to guide second-generation tyrosine kinase inhibitor selection: ready for prime time?Richard T Silver
The Oncologist|March 16, 2011
Pain in underserved community-dwelling Chinese American cancer patients: demographic and medical correlatesLara Dhingra, Kin Lam, Peter Homel, et al.
The Oncologist|March 2, 2011
Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental modelAniket Sakharpe, Guy Lahat, Taher Gulamhusein, et al.
Pageof 571